Gala Pharmaceutical Inc. Accounts Receivable, Credit Loss Expense (Reversal)
Gala Pharmaceutical Inc. reported Accounts Receivable, Credit Loss Expense (Reversal) of $0 for the 12-month period ending 2016-11-30, per its 10-K/A filed 2017-03-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2017-03-23
- Gala Pharmaceutical Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2015-11-30 was -$7.00K.
- Gala Pharmaceutical Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2015-08-31 was $0.00.
- Gala Pharmaceutical Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2015-05-31 was $7.18K.
- Gala Pharmaceutical Inc. accounts receivable, credit loss expense (reversal) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Gala Pharmaceutical Inc. accounts receivable, credit loss expense (reversal) for fiscal 2015 was $182.00.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2016-11-30 | $0.00 10-K/A · filed 2017-03-23 | |||
| 2015-11-30 | -$7.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-03-23 | -$7.00K derived: sum of 2 quarters · filed 2017-03-23 | $182.00 derived: sum of 3 quarters · filed 2017-03-23 | $182.00 10-K/A · filed 2017-03-23 |
| 2015-08-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $7.18K derived: sum of 2 quarters · filed 2016-11-04 | $7.18K 10-Q · filed 2016-11-04 | |
| 2015-05-31 | $7.18K 10-Q · filed 2016-07-15 | $7.18K 10-Q · filed 2016-07-15 |